OTCQX: CRPOF The MD&A provides commentary on the results of operations for the years ended December 31, 2022 and 2021, the financial position as at. | April 12, 2023
– FY 2021 record sales of $17,200,000 compared to $15,100,000 for FY 2020, representing a 14% increase year over year; Ceapro’s best sales performance in.